Deng S, Nie D, Huang Y, Yang Y, Liu Q, Sun Z
Biomater Res. 2024; 28:0123.
PMID: 39735729
PMC: 11676004.
DOI: 10.34133/bmr.0123.
Morelli M, Nabissi M, Amantini C, Maggi F, Ricci-Vitiani L, Pallini R
Int J Mol Sci. 2022; 23(23).
PMID: 36499683
PMC: 9738251.
DOI: 10.3390/ijms232315356.
Santoni G, Nabissi M, Amantini C, Santoni M, Ricci-Vitiani L, Pallini R
Cells. 2021; 10(8).
PMID: 34440820
PMC: 8391729.
DOI: 10.3390/cells10082052.
Chen J, Leary S, Barnhouse V, Sarkaria J, Harley B
Tissue Eng Part A. 2021; 28(7-8):330-340.
PMID: 34435883
PMC: 9057908.
DOI: 10.1089/ten.TEA.2021.0117.
Gedeon P, Champion C, Rhodin K, Woroniecka K, Kemeny H, Bramall A
Expert Rev Clin Pharmacol. 2020; 13(10):1147-1158.
PMID: 32862726
PMC: 7658017.
DOI: 10.1080/17512433.2020.1817737.
Elucidating the pathogenic and biomarker potentials of FOXG1 in glioblastoma.
Richard S, Jia-Hao Z
Oncol Rev. 2020; 14(1):444.
PMID: 32395201
PMC: 7204822.
DOI: 10.4081/oncol.2020.444.
The Transient Receptor Potential Vanilloid Type-2(TRPV2) Ion Channels in Neurogenesis andGliomagenesis: Cross-Talk between TranscriptionFactors and Signaling Molecules.
Santoni G, Amantini C
Cancers (Basel). 2019; 11(3).
PMID: 30845786
PMC: 6468602.
DOI: 10.3390/cancers11030322.
Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).
Bryukhovetskiy I, Ponomarenko A, Lyakhova I, Zaitsev S, Zayats Y, Korneyko M
Int J Mol Med. 2018; 42(2):691-702.
PMID: 29749540
PMC: 6034919.
DOI: 10.3892/ijmm.2018.3668.
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma.
Gedeon P, Schaller T, Chitneni S, Choi B, Kuan C, Suryadevara C
Clin Cancer Res. 2018; 24(15):3611-3631.
PMID: 29703821
PMC: 6103776.
DOI: 10.1158/1078-0432.CCR-17-0126.
MicroRNA-31 is required for astrocyte specification.
Meares G, Rajbhandari R, Gerigk M, Tien C, Chang C, Fehling S
Glia. 2018; 66(5):987-998.
PMID: 29380422
PMC: 5851835.
DOI: 10.1002/glia.23296.
Characterization of a FOXG1:TLE1 transcriptional network in glioblastoma-initiating cells.
Dali R, Verginelli F, Pramatarova A, Sladek R, Stifani S
Mol Oncol. 2018; 12(6):775-787.
PMID: 29316219
PMC: 5983107.
DOI: 10.1002/1878-0261.12168.
G Protein-Coupled Receptor Signaling in Stem Cells and Cancer.
Lynch J, Wang J
Int J Mol Sci. 2016; 17(5).
PMID: 27187360
PMC: 4881529.
DOI: 10.3390/ijms17050707.
Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas.
Wu X, Wu F, Xu D, Zhang T
J Neurooncol. 2016; 127(2):221-32.
PMID: 26757925
PMC: 4781890.
DOI: 10.1007/s11060-015-2039-z.
Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy.
Ramasamy T, Ayob A, Myint H, Thiagarajah S, Amini F
Cancer Cell Int. 2015; 15:96.
PMID: 26457069
PMC: 4599442.
DOI: 10.1186/s12935-015-0241-x.
Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
Soroceanu L, Matlaf L, Khan S, Akhavan A, Singer E, Bezrookove V
Cancer Res. 2015; 75(15):3065-76.
PMID: 26239477
PMC: 4526117.
DOI: 10.1158/0008-5472.CAN-14-3307.
Rindopepimut: anti-EGFRvIII peptide vaccine, oncolytic.
Gedeon P, Choi B, Sampson J, Bigner D
Drugs Future. 2015; 38(3):147-155.
PMID: 25663738
PMC: 4317793.
DOI: 10.1358/dof.2013.038.03.1933992.
G protein-coupled receptors in stem cell maintenance and somatic reprogramming to pluripotent or cancer stem cells.
Choi H, Saha S, Kim K, Kim S, Yang G, Kim B
BMB Rep. 2014; 48(2):68-80.
PMID: 25413305
PMC: 4352616.
DOI: 10.5483/bmbrep.2015.48.2.250.
Antibody-based immunotherapy for malignant glioma.
Gedeon P, Riccione K, Fecci P, Sampson J
Semin Oncol. 2014; 41(4):496-510.
PMID: 25173142
PMC: 4151824.
DOI: 10.1053/j.seminoncol.2014.06.004.
Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells.
Rowehl R, Burke S, Bialkowska A, Pettet 3rd D, Rowehl L, Li E
PLoS One. 2014; 9(6):e99091.
PMID: 24921652
PMC: 4055451.
DOI: 10.1371/journal.pone.0099091.
Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim.
Floyd D, Zhang Y, Dey B, Kefas B, Breit H, Marks K
PLoS One. 2014; 9(5):e96239.
PMID: 24805821
PMC: 4013090.
DOI: 10.1371/journal.pone.0096239.
